Prof Xavier Leleu talks to ecancer about his presentation at the MyKE20 virtual meeting.

He discussed the treatment of r/r myeloma patients, particularly the early relapse.

Prof Leleu discussed the increased need for myeloma treatment combinations with lenalidomide as more and more patients are relapsing who have been exposed to lenalidomide.

ecancer's filming has been kindly supported by Amgen through the ecancer Global Foundation. ecancer is editorially independent and there is no influence over content.